Trials / Completed
CompletedNCT02064660
The Efficacy and Safety of Periocular Acupoint Stimulation on Myopia Progression in Children
An Integrative Medical Approach of Acupoint Stimulation for Children With Myopia : A Pilot Study
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Korean Medicine Hospital of Pusan National University · Academic / Other
- Sex
- All
- Age
- 7 Years – 12 Years
- Healthy volunteers
- Not accepted
Summary
Myopia is widely one of the three commonly detected refractive errors. Myopia is usually managed by correction through glasses or contact lenses. Other alternative available include surgery, drugs and acupuncture. There are various therapeutic approaches and different points can be used in acupuncture treatment for myopia, such as auricular acupuncture, acupressure body acupuncture. However, the mechanism of acupuncture therapy for myopia is largely unknown. Furthermore, little information exists regarding the effects and safety of acupuncture for degenerative myopia in children. The investigators aimed to assess the overall effectiveness, safety of periocular acupressure for children with myopia The hypotheses of this study are as follows: Periocular acupressure is effective for myopia progression delay. The study aims to include 56 participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | massager | The patients will be doing self-stimulation using acupressure device, The acupuncture treatment will be applied two times per day for six months. Acupressure divice will stimulate for 14 minutes. Examples of acupuncture points to be used might include GB1, GB14, TE23, ST1, ST2, BL01, BL02, the Extra-point Tae-yang, In-dang. |
Timeline
- Start date
- 2013-12-01
- Primary completion
- 2014-12-01
- Completion
- 2014-12-01
- First posted
- 2014-02-17
- Last updated
- 2015-09-03
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02064660. Inclusion in this directory is not an endorsement.